SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001358403-18-000047
Filing Date
2018-05-08
Accepted
2018-05-08 16:46:51
Documents
60
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2018q110q.htm 10-Q 994186
2 EXHIBIT 31.1 exh3112018q1.htm EX-31.1 13203
3 EXHIBIT 31.2 exh3122018q1.htm EX-31.2 13495
4 EXHIBIT 32 exh3212018q1.htm EX-32 11614
  Complete submission text file 0001358403-18-000047.txt   4489218

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT blcm-20180331.xml EX-101.INS 813508
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20180331.xsd EX-101.SCH 34509
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT blcm-20180331_cal.xml EX-101.CAL 59681
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20180331_def.xml EX-101.DEF 151801
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20180331_lab.xml EX-101.LAB 479834
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20180331_pre.xml EX-101.PRE 277513
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36783 | Film No.: 18815367
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences